Infrared camera reveals escaped methane emissions from oil rig. Methane leaks from oil and gas make a major contribution to global warming.

First UN assessment since the 2021 Glasgow pledge shows methane cuts falling far short of targets needed to meet climate goals. Accelerated action could yield $330 billion in annual benefits by 2030 through improved health and reduced crop losses.

Four years after more than 100 countries pledged to slash methane emissions 30% by the end of the decade, a UN assessment has found nations are on track to deliver barely a quarter of that target.

The Global Methane Status Report, released Monday at COP30 in the Brazilian Amazon city of Belém, found that current national commitments would cut global methane emissions by just 8% below 2020 levels by 2030 – less than half of the 30% reduction target. 

The report concluded, however, that the 30% target remains technically achievable with increased investment and policy-driven reform -and it would yield some $330 billion in benefits to health and cost production – nearly double the cost of investment in mitigation.

While methane emissions are not a part of formal negotiations in the UN Framework Convention on Climate Change (UNFCC), it’s in fact the world’s second largest contributor to global warming, after CO2, and with a global warming potential 86 times greater.  

A precursor to ground-level ozone formation, methane is a contributor to air pollution-related deaths as well as reduced crop yields.  With an atmospheric lifespan of only about 12 years, reducing methane emissions can yield enormous co-benefits for health as well as reducing the pace of climate change.  

Collective, non-binding target 

The Global Methane Status Report produced by the UN Environment Programme is the first comprehensive stocktake of global progress on methane emissions since reduction targets were announced at COP26.

The assessment comes as global methane concentrations have reached the highest levels in at least 800,000 years, more than 2.6 times pre-industrial levels, with the gas responsible for roughly one-third of present-day global warming.

The new report compiled by the UN Environment Programme is the first comprehensive stocktake since the Global Methane Pledge was launched at the UN climate summit in Glasgow, COP26.

The Global Methane Pledge, a non-binding political commitment signed by 159 countries, set a collective global reduction target rather than assigning specific cuts to individual countries or sectors, leaving nations to develop their own strategies and action plans. 

“Slow climate action means that the multi-decade average of global temperatures will exceed 1.5°C within the next decade,” Ruth do Cutto, deputy climate change chief at UNEP said at a press briefing launching the report. “We must make sure that this overshoot is as short and as low in temperature as possible, and we cannot do that without curbing emissions of methane, which is responsible for one-third of today’s global warming.”

Methane’s potency as a greenhouse gas, combined with its relatively short atmospheric lifespan, makes cutting emissions one of the fastest ways to slow near-term temperature rise, often called an environmental “hand brake” by climate experts. “Lack of time is our biggest challenge,” said COP30 President Ana Toni, noting that slashing methane emissions “delivers the fastest results” for slowing warming.

Full deployment of what the report calls “maximum technically feasible reductions” could still cut emissions 32% below 2020 levels by 2030, even surpassing the pledge target.

These measures would cost an estimated $127 billion annually but deliver benefits valued at $330 billion per year by 2030, including preventing more than 180,000 premature deaths, avoiding 19 million tonnes of crop losses, and reducing global temperatures by 0.2C by mid-century.

“We’re on a highway to hell with the foot on the gas pedal,” Martina Otto, head of the Climate and Clean Air Coalition Secretariat, which produced the report with the UN Environment Programme, said at the launch event in Belém. 

“If we are heading towards the wall, you don’t just pull the handbrake a little bit. You pull it forcefully and fast. And I think that’s where we are right now,” Otto said.

Slow momentum, US wildcard

The 159 countries now signed to the pledge, up from just over 100 at launch, represent nearly half of global methane emissions. However, three of the world’s top five emitters remain outside the agreement: China, the largest overall source, India and Russia. China’s participation in a methane summit co-hosted with Brazil and the United Kingdom on the sidelines of COP30 marked a notable diplomatic shift, though Beijing remains outside the global methane pledge.

Since the pledge’s launch, projected 2030 emissions have improved modestly. Some 127 countries, representing 65% of Paris Agreement parties, now include methane mitigation measures in their latest Nationally Determined Contributions, a 38% increase from pre-2020 levels. New waste management regulations in Europe and North America, combined with slower-than-expected growth in natural gas markets between 2020 and 2024, have lowered forecast emission levels by 14 million tonnes compared with 2021 projections, UNEP found.

The emissions decrease documented in the report is relative to levels projected in 2021, not a net reduction. While methane emissions were on track to increase by 13% by 2030, that would fall to 5% if nations follow through on pledged cuts. Overall, global methane emissions continue to rise, reaching approximately 352 million tonnes in 2020 and projected to hit 369 million tonnes by 2030 under current legislation.

“If countries fully implement their existing methane plans submitted as of June 2025, global emissions could fall by about 8% this decade,” Otto said. “That would constitute the largest and most sustained decline in methane emissions ever recorded. So it works, but it doesn’t work fast enough.”

The report’s modelling does not account for the United States reversing its methane commitments. While the US was once a leading nation in advocating methane emissions cuts and a core author of the 2021 pledge in Glasgow, the Trump administration has rolled back domestic methane policies and pressured the European Union to delay implementation of new methane emissions regulations that would increase reporting transparency. Some US states, including California, have maintained stricter methane reporting requirements.

Agriculture, energy and waste lead methane-emitting sectors 

Global anthropogenic methane emissions in the current policies scenario, 1990–2050, million tonnes per year

The UNEP report found that agriculture accounts for 42% of global methane emissions, the energy sector 38%, and waste 20%. The G20 countries plus the European Union and several other developed nations are responsible for 65% of total emissions.

The energy sector offers the largest mitigation opportunity, with 72% of technically feasible reductions by 2030 concentrated in oil, gas and coal operations. More than 80% of the total reduction potential across all sectors can be achieved at costs below $36 per tonne of CO2 equivalent, with many fossil fuel measures actually profitable because they capture gas that can be sold rather than vented or flared.

Inger Andersen, executive director of UNEP, said “reducing methane emissions is one of the most immediate and effective steps we can take to slow the climate crisis while protecting human health.”

Chloe Brimicombe, a climate scientist at the Royal Meteorological Society, linked methane emissions to more frequent and intense heatwaves, which kill nearly 600,000 people annually. “Heat puts immense stress on the body, particularly for children, older people and those with chronic illness,” she said, describing methane cuts as a “fast and effective way to help protect communities from heat-related illness and deaths.” 

“Reducing methane decreases the precursors of ground level ozone, reducing cardiovascular and respiratory disease immediately,” said Courtney Howard, an emergency physician and chair of the Global Climate and Health Alliance. “Cutting methane is a win-win for health and health systems now and into the future.”

‘On the radar’

Global anthropogenic methane emissions under different scenarios, 1990–2050, million tonnes per year. 

Regional studies “continue to reveal significant underreporting of methane emissions, particularly within the fossil fuel sector,” the report found. Dan Jørgensen, European Commissioner for Energy and Housing, said nearly 90% of satellite-detected emission events still go unaddressed by governments and fossil-fuel companies.

Liz Thompson, climate ambassador of Barbados, called reining in these oversights a “matter of survival” for small island nations. “We need oil and gas companies to recognize the importance of cutting methane emissions by stopping flaring and leaks,” she said. “Over the next year, we must advance discussions so that COP31 can perhaps present a concrete proposal to initiate efforts that will lead to a legally binding agreement.”

Current methane-focused investment has reached $13.7 billion annually, up 18% in recent years but far below the $127 billion needed by 2030. Measures in the fossil fuel sector could be deployed at little to no net cost because operators can sell the captured methane, while costs for the energy sector overall represent just 2 to 4% of the industry’s 2023 income, according to the report.

“It shows that methane has made it onto the radar and that we’ve gained momentum, that cost-effective solutions exist today, essentially waiting to be brought to scale, and that the benefits are enormous,” Otto said. “We can do it, but we have to act much faster.”

China’s participation in COP30 methane summit marks a shift 

The report launch coincided with a “methane summit’’ co-hosted by Brazil, China and the United Kingdom on the sidelines of COP30. 

The summit launched a “Super Pollutant Country Action Accelerator” providing $25 million in initial funding for seven developing countries to establish dedicated national methane units, modelled on the successful Montreal Protocol ozone programmes.

China’s participation marked a diplomatic shift, as Beijing co-hosted the event despite remaining outside the Global Methane Pledge. The country is the world’s largest methane emitter, primarily from its massive coal mining sector.

“The summit not only underscores the critical role of controlling methane and other non-CO2 greenhouse gas emissions in the global response to climate change, but also encourages all parties to share the policies and actions they have taken in the emission reduction process,” Huang Runqiu, China’s environment chief, said. “Climate change is a global challenge, and addressing it requires concerted efforts from the entire world.”

The UK also led a statement signed by Canada, France, Germany, Japan, Kazakhstan and Norway committing to drastically reduce methane emissions in the fossil fuel sector, including ending routine flaring and venting by 2030 and developing a “near-zero methane intensity marketplace” by 2026 to use trade measures to reward low-emission producers.

“The global methane pledge has had an impact. It supported the reshaping of national priorities,” Otto said. However, she noted the report had to exclude the latest round of national climate plans submitted after June 2025 from its modelling. “Obviously, we have seen new coming in, but we had to do the modelling at one point, and so that became our cut-off.”

Beyond 2030, the report warned that technical fixes alone will prove insufficient. Meeting 1.5C or 2C warming targets will require combining methane controls with broader energy decarbonisation and demand-side measures, including dietary shifts and reduced food waste, potentially cutting emissions 53% below 2020 levels by 2050.

“We can still make it,” Otto said. “But it will take a whole lot of additional effort. It’s not possible if we do it half-heartedly.”

With five years remaining until the 2030 target, “the choices made in the next five years will determine whether the world seizes this opportunity, unlocking cleaner air, stronger economies, and a safer climate for generations to come,” UNEP concluded.

Image Credits: Clean Air Task Force .

Smarter analyses countries’ medicines can save millions of dollars.

Ministries of health, funders, and technical partners need to make regular smart reviews of Essential Medicines Lists the norm.

As global health faces unprecedented challenges from pandemic recovery to a changing political landscape –  resources are disappearing on a massive scale, and every healthcare dollar must work harder than ever before. 

Many countries are missing a huge opportunity: with just a few evidence-backed changes to their medicine lists, they could save lives and stretch limited health budgets much further.  

The World Health Organization (WHO) created the Essential Medicines List to help make sure people everywhere can get the medicines they need. When they work the way they’re intended, these lists help countries focus on the medicines that address the most urgent health needs – taking into account how common a disease is, how effective and safe a treatment is, and whether it offers good value. 

A strong essential medicines list makes sure the right drugs are available, in the right places, at prices people can afford. It’s one of the most powerful tools we have to reduce illness and save lives. But in many countries, the ministries of health don’t revise the list often, and aren’t transparent about their decision-making.

Systematic analysis

Rather than using a systematic analysis to make the lists as evidence-based and effective as possible, ministries of health often lean toward continuing what’s been done in the past, supplier lobbying, or the preferences of donors who support specific treatments or supply particular drugs.

That’s not just inefficient. It’s unsustainable in a world facing compounding health threats and fiscal constraints. The consequences extend beyond government budgets. 

When the right medicines aren’t on the list or aren’t stocked where they’re needed, patients are forced to pay out of pocket at private pharmacies for drugs that should be free. 

It’s unfair, it’s avoidable, and it pushes the dream of universal health coverage even further out of reach. Countries should build medicine lists that truly reflect what people need so that care becomes more accessible, more affordable, and more equitable. That’s how we turn universal health coverage from a distant goal into something real.

Tweaking Essential Drug Lists

Picture this: an old man with diabetes walks for hours to reach a public rural clinic in Uganda—only to be told the medicine he needs is out of stock.

So, he turns around and heads to a private pharmacy, where he’ll have to pay out of pocket for medicine that should have been free at the public clinic. The cost might mean skipping meals that week or delaying school fees for a grandchild. 

For many families, it’s a choice between medicine and everything else. This scene plays out every day across Uganda. At the same time, the government spends millions on newer diabetes drugs that are more expensive but no more effective than the other medicines. It’s not just bad policy. It’s a failure that costs lives. 

Our recent analysis of Uganda’s Essential Medicines and Health Supplies List showed that with just a few smart, evidence-backed changes, the system can work better: cheaper drugs, wider access, and real results for real people. 

We focused on medications for type 2 diabetes, a rapidly growing health burden across sub-Saharan Africa. 

The African region has the highest percentage of individuals with undiagnosed diabetes in the world. In Uganda, it is estimated that 2,2% of the total population had diabetes in 2024, and nearly half of patients are undiagnosed

We found that several newer diabetes medications added to Uganda’s list in 2023 were less available, less accessible, and substantially more expensive than older alternatives that had similar safety and efficacy profiles. 

For instance, replacing two newer drugs with an older, WHO-recommended drug could save Uganda’s government up to $2.65 million annually. 

Additional savings – potentially in the hundreds of thousands of dollars – could come from using higher-dose formulations that reduce packaging costs. 

These are not just theoretical calculations: they represent real money that could be reinvested in screening, diagnostics, or staffing to expand care.

Evidence-based reviews

If this approach worked in Uganda, it could work anywhere. We need to make this kind of evidence-based review a normal part of how countries choose their medicines. What set our analysis apart was the use of a structured, WHO-aligned framework, measuring not only cost and efficacy, but also cost-effectiveness, availability, and geographic accessibility. 

This kind of big-picture review almost never happens when countries update their medicine lists, especially in places with limited resources. Just as health systems measure vaccine coverage or maternal mortality, they should assess how well their essential medicine lists serve their populations. 

Countries need practical ways to make the WHO’s medicine list work for their own realities. It’s not about following guidance blindly – it’s about making smart, local decisions that truly meet people’s needs.

The math is compelling: if small changes to Uganda’s diabetes drug selection can save millions annually, imagine the global impact of systematically optimizing essential medicine lists worldwide. 

Uganda’s case shows that we could have a smarter list, stronger outcomes, and more value for every health dollar. This is not just good economics—it’s good medicine. As the world strives toward universal health coverage, optimizing essential medicine lists is a small, practical step with an outsized impact.

We’re calling on ministries of health, funders, and technical partners to make this kind of smart medicine review the norm, not the exception. It’s simple, effective, and overdue. With modest effort, countries can free up millions, improve care, and move meaningfully closer to universal health coverage.

Dr Tracy Kuo Lin is an associate professor of health economics at the University of California, San Francisco. Her research focuses on health system financing and resource allocation.

Atousa Bonyani, is a PhD student in Global Health Sciences at the University of California, San Francisco, with research interests in essential medicines lists and access to medicines.

 

 

Image Credits: Laurynas Me/ Unsplash.

US official Brad Smith (right) at a meeting to discuss a bilateral agreement with Kenyan Treasury and health officials.

The United States government is moving rapidly to secure Memorandums of Understanding (MOU) with African countries that offer limited health aid for five years in exchange for 25 years’ access to countries’ data about “pathogens with epidemic potential”.

Some commentators have described the terms of the bilateral MOUs as “extractive” as they fail to offer African countries access to the health products that might be developed from the pathogen material that they share.

The process is being driven by Brad Smith, formerly one of the leaders of Elon Musk’s Department of Government Efficiency (DOGE), who was responsible for implementing deep cuts to the US Health and Human Services (HHS) department. 

Smith is now a global health advisor in the US State Department, overseeing the reorganisation of the US President’s Emergency Plan for AIDS Relief (PEPFAR) and health grants from the now defunct US Agency for International Development (USAID).

He was part of the US delegation that met Kenyan health and finance officials last week to discuss its MOU. So too was Bethany Kozma, a former USAID official during the first Trump administration and a fervent anti-abortion campaigner. She is currently chief advisor for policy and strategy in the HHS Global Affairs Office.

Bethany Kozma, anti-abortion campaigner and chief advisor for policy and strategy in the HHS Global Affairs Office, also attended the meeting with Kenya.

Dr Chris Kiptoo, Kenyan Treasury’s Principal Secretary, reported after last week’s meeting that “both countries are finalising a bilateral agreement that aligns Kenya’s health priorities with the United States’ global health objectives, strengthening a partnership that saves lives and builds a more resilient health system for our nation”.

Meanwhile, Rwandan Health Minister Dr Sabin Nsanzimana met a US delegation headed by Dr Mamadi Yilla, US State Department deputy assistant secretary for health diplomacy, last week to discuss a new MOU.

Rwandan Health Minister Dr Sabin Nsanzimana and Dr Mamadi Yilla, US deputy assistant secretary for global health diplomacy and other officials.

Smith also led the US delegation to Zambia on Monday (17 November), where he met Zambia’s Health Minister, Dr Elijah Muchima, and Finance Minister Situmbeko Musokotwane.

The meeting aimed to “chart a new course for US health assistance to Zambia”, according to the US Embassy in Zambia.

“The new approach envisions both governments committing to funding levels and health outcome performance objectives in order to accelerate the transition from an aid-dependent health sector to a Zambian government-led health system that is able to sustainably meet the health needs of the Zambian people,” according to the US media release.

US official Brad Smith and Zambian Finance Minister Situmbeko Musokotwane.

Extensive access to data

The MOUs include clauses that would give the US extensive access to country health databases and contain punitive measures for countries that fail to provide this access or pathogen information, including unspecified “changes in the planned assistance” or total discontinuation of aid. Conversely, those that meet targets may get unspecified rewards.

While the agreements contain a list of targets  (“outcome metrics) for reducing HIV, TB, malaria, maternal and under-five mortality, and increasing measles vaccinations, details about how these will be achieved are scanty.

In contrast to the health services section, the “surveillance and outbreak response” section is far more detailed, with budget allocations and staff numbers. 

For instance, Zambia is expected to employ “1,723 field epidemiologists” in 2026 at its own expense to meet its outbreak surveillance and pathogen-sharing requirements, according to a draft seen by Health Policy Watch.

The US also notes in the draft Zambian MOU that it is making a $50 million cut to its previous commitment of $120 million in funding for antiretroviral (ARV) medicine and HIV tests due to “historic theft”. This relates to a 2021 scandal where it emerged that ARVs donated to Zambia were being sold in pharmacies.

Countries need the capacity to detect disease outbreaks within seven days and report to the US on these within a day of an outbreak being detected, according to the MOUs.

Twenty-five years’ access for five-year grants

Countries also have to commit to signing a 25-year “specimen sharing agreement”, although the MOUs only cover a five-year grant period. This agreement will cover “sharing physical specimens and related data, including genetic sequence data, of detected pathogens with epidemic potential for either country within five days of detection”. However, an annex that is supposed to set out the “elements” of the agreement is blank.

Bizarrely, the MOUs also want governments to commit to a 25-year “data sharing arrangement” for “exchanging data on the long-term performance of this MOU and for accountability to the United States Congress for appropriated funds”. However, the country grants will only run from 1 April 2026 until 2030. 

Author Emily Bass published a template for this data-sharing arrangement over the weekend, saying that it “reveals the unprecedentedly extractive nature of these ongoing negotiations”.

The US wants access to a range of data, including electronic medical records, health management and information systems, and outbreak response and surveillance data systems.

“This agreement affords the US at-will visibility into digital systems, including those, like electronic medical records, that include personal identifiable information,” Bass notes.

In the audit section, the MOUs stress that countries need to provide the US with “any data access or information needed to monitor compliance with applicable legal requirements, including to confirm no US government funding is being used for the performance of abortion as a method of family planning or to motivate or coerce any person to practice abortions”.

The MOU concludes by noting that it is not a legally binding document but “a record of the intentions of the parties”.

Bypassing WHO?

Member states started to negotiate a pathogen access and benefit-sharing system at the WHO headquarters in Geneva recently.

By placing itself at the centre of rapid information-sharing about dangerous pathogens, the US appears to be attempting to usurp the World Health Organization (WHO).

WHO member states are currently negotiating a Pathogen Access and Benefit Sharing (PABS) system that unite countries, pharmaceutical companies and non-profits in a single process aimed at speedily sharing information and developing counter-measures for pathogens that can cause pandemics. The US and Argentina are the only countries that have opted out of these negotiations.

However, if the US is the gatekeeper of pathogen information via these MOUs, this likely to fracture and slow down the global response to pandemics.

In addition, US companies could also get the first shot at developing vaccines, therapeutics and diagnostics for these pathogens.

Aggrey Aluso of Resilience Action Network Africa (RANA) warned that while governments “should explore deals that could benefit the lives of their people and their economy, such deals should not be extractive”. 

“Global health security cannot be built on coercive conditionalities,” Aluso told Health Policy Watch.

“True preparedness demands equity, respects data sovereignty, and is grounded in solidarity — not transactions that deepen inequities and silence the voices of those most affected. The current version of the proposed MOUs need an inclusive, equity-centred approach.”

Several organisations and groups are working on innovations to eliminate malaria.

This week, the world marks World Antimicrobial Awareness Week and malaria parasites, though often forgotten, are part of the range of microbes preventing us from achieving the Sustainable Development Goal of Good Health and Well-being.

Malaria remains an immense public health burden, especially in Africa. It mainly affects the poor, and remains an immense health burden for families and nations. 

Africa bears more than 94% of all malaria cases and deaths, and the disease is one of the top three causes of death. The toll is staggering: almost 600,000 lives lost each year and an estimated $127 billion drained from potential GDP. 

Although significant progress has been made over the last two decades to curb malaria deaths and illness, hurdles such as growing resistance to the current range of interventions have stalled the race to reach elimination. The global malaria community have set an ambitious target to eliminate the disease by 2030.

Africa, Japan and Europe unite

Africa, Japan and Europe are joining forces to tackle the escalating threat of antimalarial drug resistance through research aimed at developing innovations.

It is remarkable that the Ninth Tokyo International Conference on African Development (TICAD9), which took place in June,  put malaria on the agenda, with a side event demonstrating how African, Japanese and European governments and researchers are helping tackle Africa’s malaria crisis and catalyzing change. Recognizing malaria as a crisis in Africa is important to drive urgent action.

TICAD9 showcased how Japanese, African and European partners are collaborating to co-create a malaria-free future. Partners included Medicines for Malaria Venture (MMV), Nagasaki University, Shionogi and Company, the RBM Partnership to End Malaria and Kenya’s Ministry of Health, sharing their long history of collaborating on health interventions to address the burden of malaria.

Delgates attending the Ninth Tokyo International Conference on African Development (TICAD9)

Innovations include MMV’s development of the next generation non-artemisinin treatments, and its development of the long acting injectable together with Shionogi and Nagasaki University.

Other innovations include Sysmex’s rapid malaria diagnostic tests that can provide complete blood counts, making it faster and more affordable to diagnose malaria and other diseases; SORA’s Artificial Intelligence and drones that are helping detect and destroy mosquito larvae breeding sites; and Eiken’s gene amplification technology that can diagnose malaria early (when it could be missed by microscopy or rapid detection tests). These present new frontiers in North-South collaboration. 

These achievements strive to change the malaria elimination trajectory at a time when the famous perfect storm of antimalarial resistance threatens our gains.

Increasing access to malaria interventions, especially for the poor, is critical.

An essential part of the Big Push towards malaria elimination is increasing accessibility, acceptability and adaptability of existing tools, while developing and rapidly introducing new ones. It is only through this route that we can combat emerging threats, such as antimalarial drug resistance, insecticide resistance, climate change, and rising humanitarian crises. 

Going the extra mile

Together with Japanese and European researchers, malaria-endemic countries are going the extra mile to invest in research capacity, knowledge exchange and technology transfer to give the people most affected by malaria more access to the innovations they need at an affordable price.

So, while we have averted 12.7 million malaria deaths in the past two decades and have a stronger suite of tools – from new medicines and vaccines to duo-insecticide mosquito nets and AI-driven interventions – it is important to appreciate that Global North-South Partnerships are driving progress forward. Today, these partnerships necessitate exploring new frontiers and strengthening collaborations, including the ones between Japan and Africa.

Malaria elimination is possible, but we must commit to increasing resources if we want to achieve this.

In the face of limited and competing resources, we must start to see malaria as more than a disease burdening endemic countries. It is an intersectional global health challenge that undermines health systems, threatens international development goals, and weakens global health security.

Several African countries demonstrate that malaria does not have to be an inevitable crisis for the continent. Cabo Verde and Egypt recently received malaria-free certification from the World Health Organization. Rwanda has drastically reduced its burden of malaria over the last five years, and Eswatini and Botswana are  nearing malaria elimination.

With strong partnerships, increased financial, human and infrastructural investments and committed governments, the disease can be made history.

It is equally important that we do not rest on our laurels because of the previous progress made but increase investments towards malaria, especially in the face of the expanding threat of antimalarial drug resistance in Africa.

Aden Duale is the Minister of Health in Kenya. As the Member of Parliament for Garissa Township since 2007, he has implemented significant health programs, played a crucial role in responding to health crises such as the COVID-19 pandemic, and advocated for vital health reforms. His areas of expertise include health policy and administration, public health management, and community health initiatives. 

Cristina Donini is the Executive Vice President and Head of Research, Early Development and Modelling at MMV, where she manages antimalarial drug development projects and collaborates on new candidate development. Passionate about the malaria eradication agenda, she has previously held roles at GSK, Serono, and Merck Serono, where she led a team in Pharmaceutical Chemistry. Cristina holds a PharmD and a doctorate in Pharmaceutical Technology from the University of Parma, Italy, in collaboration with Purdue University.

 

Dr Inaoka Ken Daniel is a distinguished professor at the Institute of Tropical Medicine at Nagasaki University, where he specializes in tropical medicine and infectious diseases. His research focuses on various aspects of tropical medicine, including malaria, dengue fever, and other vector-borne diseases, contributing significantly to the global understanding of these conditions.

Dr Takaya Kenji is a Senior Scientist at Shionogi & Co., Ltd. With a strong academic foundation in pharmaceutical sciences and extensive experience in drug discovery and development, Dr Takaya has contributed significantly to the development of new medications that address unmet medical needs. His research interests include antimicrobial resistance, antiviral therapies, and the optimization of drug formulations. 

Dr Michael Adekunle Charles is CEO of the RBM Partnership to End Malaria. He is dedicated to putting malaria high on the global health agenda and pursuing interventions that address the disease and it intersection with factors such as climate, gender, poverty and inequity. Dr. Charles also served at the International Federation of Red Cross and Red Crescent Societies for 17 years, where he was at the helm of strategically aligning the organisation’s Africa vision to meet evolving needs.

The synthesis report follows the launch of the Belém Health Action Plan at COP30, a voluntary best practice framework to assist governments in adapting their health systems for climate change.

Nations worldwide must finance and implement climate adaptation measures for health systems or risk losing millions of lives as extreme weather, rising temperatures, and intensifying heat threaten healthcare access for nearly half the global population, according to a report published Friday by the World Health Organization and Brazil.

The special report, released at the COP30 summit in Belém, follows Thursday’s launch of the Belém Health Action Plan, which won backing from roughly two dozen countries but secured no financial commitments from governments.

The only funding to support the plan came from philanthropies: a $300 million one-time grant. The report estimates health system adaptation needs at $22 billion per year by 2035.

“The climate crisis is a health crisis – not in the distant future, but here and now,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “This special report provides evidence on the impact of climate change on individuals and health systems, and real-world examples of what countries can do – and are doing – to protect health and strengthen health systems.”

The past decade has been the hottest on record, with global temperatures exceeding 1.5°C above pre-industrial levels for the first time in 2024.

Updated Climate Tracker projections published at the UN climate summit on Wednesday show the world on track for 2.5°C of warming, while the UN Environment Programme projected last week that a business-as-usual scenario has the world heading for 2.8°C. Every fraction of a degree endangers millions.

“Many health systems are fragile, lacking climate-trained personnel, resilient infrastructure and adequate surveillance,” said Simon Stiell, executive secretary of the UN Framework Convention on Climate Change. “Watching super typhoons and flash floods rip through hospitals and local health clinics is heartbreaking, but lamenting is not a strategy. We need real solutions.”

Simon Still, executive secretary of the UNFCCC, addresses COP30’s opening plenary.

“The real challenges people face, such as extreme heat, air pollution, infectious diseases, mental health and food insecurity – humanity can only win this global climate fight if we connect stronger climate actions to people’s top priorities in their daily lives, and there are few higher priorities than our health,” Stiell said.

The report does not present new evidence, functioning instead as a synthesis of the best available science and data on the risks posed to unprepared health systems by climate change, drawing on academic literature, government and UN reports, and real-world case studies.

“Recent tragedies show that now is the time to implement policies and actions that address the impacts of climate change on health,” said Alexandre Padilha, Brazil’s health minister. “The Belém Health Action Plan and this report offer countries the tools they need to turn scientific evidence into concrete action.”

As storms batter coastlines, floods displace communities, and droughts fuel conflict and hunger, the report paints a picture of health systems under mounting strain. The familiar but alarming statistics form the case to policymakers to invest in adaptation and join the Belém plan.

More than 540,000 people now die annually from extreme heat, a 63% rise since the 1990s. Between 3.3 and 3.6 billion people live in regions highly vulnerable to climate change.

One in twelve of the world’s 200,000 hospitals face the risk of total shutdown due to extreme weather events under high-emissions scenarios, with more than 70% of at-risk facilities located in low- and middle-income countries. Hospitals and health facilities are also 41% more likely to suffer damage from extreme weather events than in 1990.

“Climate change is an unavoidable reality that challenges public health and adds pressure on already overwhelmed systems,” Padilha said, calling policies to protect the health sector one of the “most strategic decisions of the 21st century.”

“Protecting lives, reducing inequalities, and bolstering the resilience of health systems are no longer just goals – they have become ethical and democratic imperatives,” he said.

Mitigation left out of the main Belém text 

Brazil’s COP30 presidency chose the Amazon city of Belém in an effort to remind negotiators of the planet they are fighting to protect.

While the report and Belém Health Action Plan focus on preparing health systems for climate impacts, the synthesis document draws a clear conclusion about what would most protect those systems: cutting emissions.

“The evidence is clear: urgent and sustained mitigation across all sectors is the single most important health adaptation intervention,” states the executive summary. “There are profound physical, financial, and technological limits to adaptation, and health systems cannot remain resilient in a world of unchecked warming.”

By reducing emissions, health systems would face less extreme weather events, fewer heat deaths, and smaller disease burdens, making adaptation needs less severe in the first place.

That finding sits awkwardly with the Belém Health Action Plan itself, which contains no references to phasing out fossil fuels, the main driver of climate change.

The fossil fuel omission came at the explicit instruction of the Brazilian COP30 presidency, according to people familiar with the negotiations, likely to open the door for more nations to sign on who will not commit to language on fossil fuel phase-out.

What the report identifies as “the most effective measure” to protect health systems is excluded from the political Belém framework, which requires endorsement from governments, instead relegated to a supporting document with no political weight.

“When COP30 delegates leave Belém, success will be measured by the courage governments have demonstrated to act on what is already known: that fossil fuels are destroying people’s health,” said Jeni Miller, health lead at the Global Climate and Health Alliance. “To ignore these realities would be to betray both science and humanity.”

A $20 billion gap 

Adaptation needs for health systems estimated in the COP30 special report.

Direct health sector adaptation interventions will require more than $22 billion annually by 2035, according to the report, approximately 7% of total adaptation financing needs in climate-vulnerable countries.

Current health-specific climate finance reaching those countries totals around $500 to $700 million annually, representing 2% of adaptation funding and 0.5% of multilateral climate finance.

Climate and health finance has grown considerably in recent years, rising tenfold from less than $1 billion in 2018 to $7.1 billion in commitments between 2018 and 2022, according to analysis published earlier this year by the Rockefeller Foundation, WHO and other partners.

In 2022, this included $4.8 billion from bilateral donors, $600 million from multilateral development banks, $1.5 billion from multilateral health funds, and $130 million from philanthropies.

The share of climate finance targeting the health sector increased from 1% in 2018 to 9% in 2022, the only sector apart from education to see an increase. Yet these flows remain far below estimated needs, and more than 90% of health adaptation funding from development banks arrives as loans rather than grants.

“The evidence is clear that we have been too slow to act on climate change and we are now ill-equipped to cope with rising temperatures across the world,” said Alan Dangour, health and climate lead at the Wellcome Trust.

The report identifies persistent gaps in readiness. Only 54% of national health adaptation plans assess risks to health facilities. Fewer than 30% of health adaptation studies consider income, 20% consider gender, and less than 1% include people with disabilities. More than 60% of National Adaptation Plans have no formal tracking or evaluation in place.

“Extreme heat, air pollution and infectious disease all hit the most vulnerable hardest: children, pregnant people, older adults, outdoor workers, and communities with the fewest resources,” Dangour said.

“At COP30 and beyond, governments must act on the science – cut emissions, invest in adaptation, and put health at the heart of climate action. Lives, economies, and our future depend on the solutions we deliver now.”

Image Credits: COP30, COP30.

Child
Children’s health suffers in households where their mothers are abused.

Noma Bolani has a clear memory of her abusive father stopping the car in the middle of the highway in Durban, South Africa and asking her mother to get out. 

She was just six years old, but Bolani followed her mother out of the car, and together they sought help from a passing motorist. 

Bolani is now 38, and has anxiety stemming from early childhood experiences related to growing up with an abusive father and witnessing her mother being at the receiving end of emotional and financial violence.  

Ayesha*, 34, from New Delhi, India, grew up watching her mother being subjected to physical, emotional and financial violence from her father. He would sometimes also resort to silent treatment that would last weeks, refuse to pay school fees for Ayesha and her sister and resort to physical violence using belts, shoes and, at times, utensils.  

Ayesha suffers from Polycystic Ovary Disease (PCOD) that affects the regularity of her periods and causes hormonal changes. Her doctor believes the stress she was subjected to as a child played a significant role in worsening her PCOD.

Like Bolani, Ayesha also carries mental health scars from watching violence directed at her mother.

When mothers are at the receiving end of violence, it can make their children physically ill, according to a growing body of research. 

Impact on children’s health

Health data from 37 countries in sub-Saharan Africa found that children under the age of five whose mothers experienced intimate partner violence (IPV) were more likely to develop diarrhoeal disease and symptoms of acute respiratory infections, according to a study published in The Lancet last year.

It called for tailored interventions to address childhood morbidity and mortality attributed to IPV in “priority countries” – Burkina Faso, Burundi, Chad, Comoros, Gabon, Liberia, Nigeria, Sierra Leone, South Africa, and Uganda.

“The most important thing is actually the cumulative effect,” said Abel Dadi, lead author and a social epidemiologist at the Menzies School of Health Research at the Charles Darwin University in Australia.

His study looked at exposure to three kinds of violence – physical, sexual and emotional. “When they come together, their effect increases,” he said.

Dadi’s team also found a strong link between IPV and stunting in Burundi, and IPV and children being underweight in Burkina Faso, although the results were not consistent across all countries. 

What is not yet clear is the exact pathway of how IPV directed towards the mother affects a child’s physical health.

Maternal care
A mother and newborn at a health center in the Patna district of Bihar, India. Babies’ health and well-being is deeply affected by their mother’s health.

Pervasive violence

The World Health Organization (WHO) recognizes that violence against women is a major public health issue. Globally, one third (27%) of women experience IPV in their lifetime, according to WHO figures. In sub-Saharan Africa, these rates are even higher, with 45·6% of women experiencing IPV in their lifetime.

Young women aged 15 to 19 are the most affected by IPV. By the time they are 19 years old, almost a quarter of adolescent girls (24%) who have been in a relationship have already been physically, sexually, or psychologically abused by a partner, according to WHO data.

However, while it is widely accepted that intimate partner violence affects a woman’s mental, physical and sexual health at risk, its impact on children has not received the same attention. 

But a child’s health and well-being are completely dependent on their mother during pregnancy, and heavily dependent in the early years, so a mother’s health and well-being directly affects her child’s health.

The WHO, which developed a toolkit with UN Women to prevent violence against women in 2019, acknowledges that violence against women and against children often occurs in the same household. 

Psychiatrists like Bessel van der Kolk, who wrote ‘The Body Keeps the Score’, and Gabor Mate, author of ‘The Myth of Normal’, have also brought the lifelong impact of childhood trauma into the public domain, particularly of growing up with abusive parents.  

But IPV has long been seen as a criminal issue rather than a health issue. In India, for example, hospitals have only recently started to offer health workers training to see it as a public health problem.

“I don’t think it is a well-understood field of work in terms of a response from the courts or from the state’s response to children’s rights,” said Julie Thekkudan, South Asia consultant at Equality Now, a global non-profit that advocates for women’s and girls’ rights. 

Each dot represents a different country in the region.

There has been progress, with signs that IPV is reducing in some low- and middle-income countries due to progress in women’s empowerment.  

The reason women find it hard to leave abusive relationships, especially in the Global South, is that they have been socialized to tolerate violence, according to Thekkudan.

In societies that favour sons and devalue daughters, girls are socialized into believing that their “purpose in life is to get married”, she explained. Staying in a marriage, even if it is abusive, and seen as part of “making sure that your family honor is maintained”, Thekkudan added. 

That, in addition to the fact that women don’t always have the financial ability to leave, makes it a harder choice. 

Dadi said that any intervention design on maternal health should consider intimate partner violence as well as the mental health of the mother. Currently, most of these kinds of interventions are concentrated in high-income countries, according to research.

On average, countries that do better on gender equity indexes usually also experienc lower levels of violence against women, according to takeaways published in The Lancet.

But a woman’s higher economic status can also make her vulnerable. One study from sub-Saharan Africa showed that women’s employment, especially if they were the sole earners or if they earned more than their male partner, was linked to a higher level of intimate partner violence.

Any solution “has to be a multi-pronged, multi-level”,  said Thekkudan. “I don’t think there is one solution that will change the entire system or the structure.”

*Name changed to protect identity

Image Credits: Photo by Alex Pasarelu on Unsplash, BMGF, World Bank.

Belém framework wins backing from two dozen nations, but health remains outside formal UN climate negotiations.

Brazil launched a sweeping climate-health action plan on Thursday, named after the COP30 host city in the Amazon, winning initial endorsements from roughly two dozen countries for a voluntary framework calling on nations to strengthen disease surveillance, build climate-resilient infrastructure, and protect vulnerable populations from the health impacts of rising temperatures and extreme weather.

The Belém Health Action Plan outlines 60 action items across surveillance systems, evidence-based policies, and health innovation to address the health risks facing 3.3 billion people globally affected by the climate crisis.

“The climate crisis is one of the most significant health challenges of our time,” states the plan, developed by Brazil’s health ministry in consultation with the WHO. Countries that endorse the voluntary framework will report their progress through UN climate negotiations during the second Global Stocktake at COP33 in 2028.

The World Health Organization calls climate change “the greatest single risk to humanity,” and the World Bank estimates it could cause up to 15.6 million deaths between 2026 and 2050, with health impacts costing $8.6 to $15.4 trillion by mid-century.

Initial supporters include European Union states such as France and Spain, small island nations like Tuvalu, African countries from Congo to Zambia, and others including Canada, Japan, the United Kingdom and Malaysia.

Brazil’s health minister Alexandre Padilha said the plan had received backing from more than 80 nations and institutions, though the vast majority comprises civil society organisations like the Global Climate and Health Alliance, global health actors including Medicines for Malaria Venture and Drugs for Neglected Diseases Initiative, and UN agencies such as UNFPA, UNICEF and UNITAID.

“We expect to have more by the end of the day and the end of the COP,” Padilha said, adding the presidency would continue “trying to engage and mobilise” more countries. “There’s a very strong commitment from our government and ministers of health in this plan.”

Delegates gather in the plenary hall of COP30 in Belem for the launch of the Brazil-WHO-led health-climate adaptation plan.

The voluntary nature of the framework and broad support for the Alliance for Transformative Action on Climate and Health (ATACH) — a WHO-led initiative launched at COP26, which now counts 101 members — suggest endorsements will likely grow, but implementation remains uncertain. WHO will serve as the secretariat for the Belém plan, measuring outcomes through the ATACH framework.

The sole explicit dissent Thursday came from Egypt, part of the Baku coalition of previous COP presidencies that helped draft the plan. Egypt’s health minister expressed willingness to join but voiced “concern about the reference to the inclusion of LGBTIQ+ individuals, as such patterns fall outside the nationally recognised policy frameworks in the cultural context of Egypt.”

Other coalition members, the United Arab Emirates and Azerbaijan, expressed political will to continue discussions but stopped short of endorsement, instead noting they had “contributed” and “noted with interest” the framework’s goals.

“We have to look at the impact of climate change, one of the main threats to public health in the world today,” Padilha said. “Scientific evidence has shown clearly that the climate crisis is first and foremost a crisis of public health throughout the world.”

“The time of warnings has finished. Now we are living in a time of consequences,” he added. “The climate has already changed, so we have no alternative but to have public policies to adapt and face climate change.”

No money from nations

The voluntary adaptation framework was endorsed by around countries but faces billions in funding shortfalls.

The launch came with no new financial commitments from endorsing nations. The sole funding announcement came from a coalition of philanthropies including the Gates Foundation, Wellcome Trust, and Rockefeller Foundation: a $300m one-time grant to support climate-health adaptation measures.

That figure is dwarfed by estimates that low- and middle-income countries require at least $11 billion annually just for basic health adaptation covering only disease control for malaria, dengue, diarrheal diseases, heat-related mortality, and essential surveillance improvements, according to the UN Environment Programme.

“Health systems, already stretched and underfunded, are struggling to cope with these growing pressures, and most are still unprepared for what is coming,” said Marina Romanello, executive director of the Lancet Countdown at University College London. “Existing finance falls short by billions. Without urgent investment, we will not be able to protect populations from escalating climate impacts.”

The $11 billion annual UNEP pricetag excludes respiratory illnesses, malnutrition, mental health services, additional infectious disease programs, workers’ health protection, supply chain adaptation, and health system decarbonisation — most of what the Belém plan contains. The UNFCCC estimates global health adaptation will require $26.8 to 29.4 billion annually by 2050.

Current health-specific climate finance reaching those countries totals perhaps $500 to $700 million annually, representing 2% of adaptation funding and 0.5% of multilateral climate finance. “With regards to finance, that reality is that we have a deficit that is quite colossal,” said Carlos Lopes, Special Envoy for Africa to the COP30 Presidency.

A WHO survey of National Health Adaptation Plans found all included climate-health risks. But just 28 nations worldwide have completed such plans.

As temperatures continue rising and extreme weather events intensify, pressure mounts for health system adaptation at a moment when global health financing faces unprecedented strain. Overall development assistance for health dropped 21% from nearly $50 billion in 2024 to $39 billion in 2025, driven largely by US withdrawal from global health programs. The WHO itself faces budget shortfalls of 15-20%.

Climate-health financing has grown from less than $1 billion globally in 2018 to $7.1 billion in 2022, the only aid sector to grow in that time apart from education, according to Rockefeller Foundation analysis. But substantial portions arrive as loans: 24% of bilateral climate-health funding and more than 90% from the Asian Development Bank and Inter-American Development Bank.

Many developing countries now spend more on servicing debt than on healthcare, with low-income countries spending roughly 300 times less per capita on health than wealthy nations.

That finance shortfall impacts their ability to implement adaptation plans like the Belem Framework: A 2021 WHO survey found that while half of the countries reported having national health-climate strategies, less than a quarter achieved high implementation levels. Insufficient financing was identified as the key barrier by 70% of responding countries.

Health’s struggles mirror wider climate adaptation finance gaps. At COP26 in 2021, developed countries pledged to triple overall adaptation finance from 2019 levels to at least $120 billion per year by 2025. Actual flows across all sectors totalled $26 billion in 2023.

Money will determine whether Belém becomes an implemented plan or another symbolic declaration. Without tens of billions in annual funding, it will likely follow previous COP health commitments that failed to translate rhetoric into action.

“The Belém Health Action Plan gives us the blueprint,” said Simon Stiell, executive secretary of the UN Framework Convention on Climate Change. “What we need now is sustained, coordinated and well-financed action to turn its promises into protection for all.”

What’s the plan?

Launch event for the Belem Health Action Plan at COP30.

The Belém plan functions as a framework of best practice recommendations for adapting health systems to the climate crisis, containing no legally binding requirements or targets.

Instead, the document outlines recommendations organized around surveillance systems, policy interventions, and infrastructure overhauls that officials say are essential to protecting billions from climate-driven health crises. The one specific requirement: Countries that endorse it will report progress through the Paris Agreement’s Global Stocktake by COP33 in 2028, with no enforcement mechanisms or compliance requirements.

“For decades, WHO has been calling for action to adapt health systems and build resilience to climate change,” said Tedros Adhanom Ghebreyesus, WHO director-general. “The Belém health action plan is how we can do that.”

“Health systems themselves are affected by climate change, compromising their ability to deliver life-saving care when people need it most,” he said. “There can be no healthy people on a sick planet.”

The first focus: building the capacity to see threats coming. The framework calls for climate-informed health monitoring that links meteorological agencies with health institutions, using predictive modelling to trigger early warnings before heat waves, floods, or disease outbreaks overwhelm communities. Surveillance should also track which populations face the greatest risks, data officials say is often missing.

The second area addresses policy interventions to protect communities, including clean energy and sustainable transport, heat protection for workers, mental health support woven into climate response, and targeted measures for Indigenous peoples and persons with disabilities.

”For many countries, adaptation is a question of survival in the short run. If you don’t adapt, it threatens the coverage of health services of patients and professionals who are already facing adverse conditions,” Padhila said. “If we don’t adapt, we are going to increase inequality. In short, if you don’t adapt, we will kill people.”

Water & power

“It’s about the billions of people that we have the mandate here to make sure that we can change their lives, promoting health,” said Princess Abze Djigma of Burkina Faso.

Finance will determine whether the Belém framework’s most ambitious element, climate-resilient infrastructure, can be delivered.

The plan envisions health facilities built to withstand climate shocks, renewable energy powering clinics, telehealth platforms extending care, and strategic stockpiles of temperature-stable medicines and vaccines. It calls for “integrated methodologies linking environmental, meteorological, social, climate and health monitoring data” with real-time surveillance and digital technologies as “structural components.”

The problem: roughly 100,000 health facilities in sub-Saharan Africa lack reliable electricity, affecting nearly a billion people worldwide. Up to 70% of medical equipment in developing countries sits unused due to power failures.

Cold chains for vaccines, digital surveillance systems, early warning platforms, and telehealth services all depend on reliable power that serving populations don’t have. Closing the healthcare electrification gap by 2030 would cost $4.9 billion, about $5 per person affected over six years. That’s less than one year of current global climate-health spending.

“It’s about the billions of people that we have the mandate here to make sure that we can change their lives, promoting health,” said Princess Abze Djigma of Burkina Faso. “It is very important we have the policies… working on the value chains of electricity to make sure that our babies, who are getting born without electricity,” have access to care.

Water and sanitation infrastructure are equally critical, she noted. “If we bring water, we bring sanitation. There is already a disease that we will put away. We can tell our boys and girls to wash their hands, but how could they do it if there is no water at the school?”

Just three nations have completed all four ATACH assessments as of 2025.

The Belém plan’s success will depend not just on building infrastructure, but on countries’ ability to track and report progress. WHO will measure implementation through ATACH, its Alliance for Transformative Action on Climate and Health, which already requires members to complete vulnerability studies, adaptation plans, emissions inventories, and decarbonization roadmaps.

The record so far suggests those demands exceed many countries’ capacity. Four years after ATACH’s launch in 2021, only three countries—France, Japan, and the UK—have completed all four assessments. Across 88 countries with available data, roughly 35-40% completed vulnerability assessments and 30% finished adaptation plans. In Africa, fewer than 10 of 29 ATACH members have completed vulnerability assessments.

The Belém plan now adds reporting requirements on top of those existing gaps: tracking mental health impacts, monitoring workers’ heat exposure, establishing community resilience programmes, and climate-proofing supply chains, all by 2028.

That creates an impossible bind. France, Japan, and the UK have the technical capacity and resources to meet these demands. Many other countries lack not only the expertise for complex reporting systems, but the basic infrastructure, electricity and water, that the plan assumes as a foundation.

“Finance is still the bottleneck for us,” Princess Djigma said.

Fossil fuel phase-out excluded

Delegates arrive for the opening day of COP30 on the edge of the Brazilian Amazon.

Notably absent from the plan is any reference to phasing out fossil fuels, the main driver of climate change and the resulting heat, extreme weather and air pollution killing approximately 8m people annually from respiratory and cardiovascular diseases.

The omission came at the explicit instruction of the Brazilian COP30 presidency, according to people familiar with the negotiations.

The exclusion comes as the International Energy Agency warned Wednesday that global oil and gas demand will rise for the next 25 years if countries do not change course. Until this year, all of the Paris-based body’s modelling assumed fossil fuel consumption would peak this decade.

“Climate change is declining — and declining rapidly — in the international energy policy agenda,” said Fatih Birol, the IEA’s executive director. “And this is happening while 2024 was the hottest year in history.”

Fifteen countries allocated more resources to fossil fuel net subsidies than their entire national health budgets.

Birol’s findings align with the Lancet Countdown report published ahead of the summit, which found the 100 largest oil and gas companies have production strategies that put them on track to exceed their share of production consistent with 1.5 °C of heating by 189% in 2040, up from 183% in March 2024.

Private bank lending to fossil fuel activities surged 29% to $611 billion in 2024, exceeding green sector lending by 15%. Some 73 of 87 countries reviewed provided net explicit fossil fuel subsidies in 2023, allocating nearly $1 trillion in direct support. Including indirect subsidies, that figure rises to over $7tn, according to the International Monetary Fund — more than governments spend annually on education and about two-thirds of what they spend on healthcare.

The declining political attention extends to international engagement: Mentions of health and climate change by governments in their annual UN General Assembly statements declined from 62% in 2021 to 30% in 2024, according to the Lancet Countdown.

“Record deaths from climate-driven wildfires in 2023 show that there’s no adaptation without mitigation,” said Nina Renshaw, head of health at the Clean Air Fund. “Ministries of Health and Finance won’t be able to bail hospitals and clinics out of the climate emergency if governments don’t stop the emissions which are already causing unprecedented harm.”

‘More than dialogue’

Delegates convened for the first-ever Health Day at a UN climate summit in Dubai.

The Belém plan follows a pattern established at recent climate summits: the COP28 Dubai Health Declaration signed by 143 countries, the Baku Coalition for Climate and Health launched last year, and efforts stretching back to Glasgow in 2021. Like those efforts, Belém is a non-binding, voluntary process taking place outside formal UN negotiations.

Criticisms of the outcomes of Dubai and Baku describe their outcomes as symbolic gestures that generate attention but fail to secure funding, sustained commitment, or implementation. Officials on Thursday repeatedly stressed the need to break the holding pattern.

“This gathering must be more than dialogue,” said Jarbas Barbosa, director of the Pan American Health Organization. “It must galvanise collective action and inspire new policies dedicated to protecting everyone’s health from the worsening effects of climate change.”

“The climatic crisis is fundamentally a health crisis,” Barbosa said. “We are not talking any more about distant or possible threats. Climate change is a present and growing reality.”

Whether the Belém framework can overcome the obstacles that have stymied previous declarations — insufficient financing, limited technical capacity, competing priorities — remains uncertain. But Padilha argued the world has no choice but to try.

“We are faced with a dilemma: we either continue to speak and speak and talk, or we can walk the walk and make the political commitment to do so,” he said. “We cannot accept the erosion of multilateralism in global health. Those who deny multilateralism are surrounding us. We will not listen to them.”

Image Credits: COP30, COP30, COP30, COP30, COP30, COP30, WHO .

Andrew Black, Acting Head of the Secretariat of the WHO FCTC, and Reina Roa, President of the COP11, at the opening press conference.

GENEVA – Global health leaders are calling for robust new measures to combat the use of tobacco and related products, including restrictions on flavours to curb the surge in e-cigarettes use in adolescents and filter bans to protect the environment. 

These and other proposals will be debated over the next two weeks as over 1,400 delegates representing governments, international organisations and civil society gather in Geneva for the World Health Organization’s (WHO) Framework Convention on Tobacco Control (FCTC).

“The meeting will bring the world together to energize international cooperation and foster political will to address the global tobacco epidemic. Well over seven million people die each year because of tobacco,” said Andrew Black, acting head of the WHO FCTC Secretariat, at the opening press conference for the 11th Conference of Parties (COP11). 

The FCTC provides a binding legal framework and a package of control measures for the parties. Since it came into force 20 years ago, significant progress has been made. Today, over 75% of the global population – more than 6.1 billion people – are covered by at least one of the WHO’s MPOWER tobacco control measures, which are a set of cost-effective technical recommendations designed to reduce tobacco use.

“Since the FCTC came into effect, tobacco use has declined by a third worldwide, despite the tobacco industry’s efforts to undermine it,” noted WHO Director-General Dr Tedros Adhanom Ghebreyesus.

New products undermine successes

But this progress is facing increasing challenges as the tobacco industry markets new nicotine products such as e-cigarettes, heated tobacco products and nicotine pouches – all of which are now widely available in many countries.

Data presented by the WHO shows that, on average, e-cigarette use among adolescents aged 13 to 15 is nine times more prevalent than among adults in the same country.

Health bodies and researchers claim that the industry’s focus on sweet and fruity flavours, bright packaging and social media promotion is designed to attract young consumers.

The regulation of these new products is lagging. By the end of 2024, 62 countries still had no policy in place regarding electronic nicotine delivery systems (ENDS) and 74 countries had no minimum age for purchasing e-cigarettes. Only seven countries ban all characterising flavours in ENDS, excluding those that prohibit sales entirely.

Call for ban on filters, debate on flavours

The FCTC will address the obligation of parties to prevent and reduce nicotine addiction for the first time, said Kate Lannan, senior lawyer to the Secretariat of the WHO FCTC.

The COP11 agenda includes robust regulatory proposals. High-level discussions are expected on extending existing regulations or bans on flavours across all products and member countries, and on holding the industry legally responsible for causing harm to public health.

“This is the first time the conference of the parties will be specifically addressing the obligation of parties to prevent and reduce nicotine addiction,“ said Kate Lannon, senior lawyer at the WHO FCTC Secretariat, with regard to evolving nicotine addiction among young people.

Protecting the environment will also be a focus. There are growing concerns over cigarette filters, which are made of cellulose acetate, a type of single-use plastic. The WHO and several member states, including the Netherlands, are urging parties to consider banning filters altogether. 

They argue that this would reduce toxic pollution and address the misconception among consumers that filters substantially reduce health risks. 

“These filters on cigarettes don’t provide any meaningful increase in the safety of cigarettes,“ explained FCTC’s Secretary Black.

Delegates will also discuss implementing a levy for environmental damage or establishing Extended Producer Responsibility (EPR) measures to collect funds to mitigate environmental harms across the entire tobacco product life cycle. Negotiations on increasing taxes on tobacco products are expected to continue.

Industry interference is the biggest barrier to regulation

Tobacco industry interference has become more aggressive, according to the Global Tobacco Industry Interference index (GII), with countries like the United States, Switzerland and Japan among the worst regulated.

Industry interference is reported as the “biggest constraint and barrier” to implementing the Convention. According to the 2025 Global Tobacco Industry Interference Index (GII), the industry is becoming “increasingly aggressive” in its tactics. 

These include “harm reduction” narratives, targeting non-health departments (like finance and trade), “political capture” of delegations, and using “greenwashing” tactics – such as funding tree planting or cigarette butt clean-ups – to improve its public image and gain access to officials.

According to the University of Bath’s monitoring organisation, Tobacco Tactics, the World Vapers’ Alliance (WVA) is funded by the tobacco industry. The WVA has argued against flavour bans and tax increases, claiming that they disregard the needs of adult vapers.

In response, the FCTC Secretariat has urged all parties to fully implement Article 5.3, a legal clause requiring governments to protect their public health policies from industry interests.

Public health analysts suggest that failure in tobacco control is rooted in industry interference and a lack of political will, not a lack of regional capability or money. 

For example, while the European region is set to miss its 2025 reduction target, the Netherlands maintains one of the lowest levels of industry interference globally.

Meanwhile, Ethiopia, a low-income country, ranks fifth best in the Global Interference Index, using robust legal protections and strong cross-government coordination to build a resilient system against industry interference.

Image Credits: Felix Sassmannshausen, Stop Tobacco.

Cholera oral vaccine Sudan
A child gets an oral cholera vaccine.

South Africa aims to become the first African country to manufacture a cholera vaccine with the launch this week of a clinical trial of an oral vaccine developed by local company Biovac.

The vaccine candidate was developed thanks to a technology transfer partnership between Biovac and the International Vaccine Institute in South Korea in 2022.

At present, the only manufacturer of a cholera vaccine is EuBiologics in South Korea, which makes a vaccine marketed as Euvichol-Plus.

This has severely constrained the global supply of cholera vaccines, leading to rationing and global shortages as cholera outbreaks have surged worldwide, spurred by waves of climate-related weather crises and conflict, particularly in Africa.

This week, Biovac announced the launch a Phase 1 safety trial of the vaccine at the University of the Witwatersrand in Johannesburg.

If the vaccine is deemed safe, in the larger Phase 3 study, the Biovac Oral Cholera Vaccine will be compared to Euvichol-Plus, EuBiologics vaccine.

The only cholera vaccine in the world is made by South Korea’s EuBiologics. Biovac was assisted in developing its vaccine by a technology transfer agreement with the International Vaccine Institute in South Korea.

“Biovac is proud to be manufacturing this vaccine entirely in South Africa, the first time in over fifty years that such a milestone has been achieved,” said company CEO Dr Morena Makhoana.

Biovac has evolved from a vaccine distributor to a” full-scale manufacturing hub”, the company noted in a statement.

“Vaccines manufactured in South Africa usually receive the active pharmaceutical ingredient from abroad, with the final vaccine being completed in South Africa (often referred to as ‘fill and finish’), but in this case, the vaccine candidate is being manufactured from start to end by Biovac,” the company added.

“If the trials are successful, South Africa will become the first country on the continent to produce a cholera vaccine,” Makhoana said. “This development addresses a critical, life-saving need, given the ongoing global shortages of the vaccine amid recurring cholera outbreaks.”

Depending on the trial outcomes, the vaccine could be approved and ready for use in Africa in 2028.

Enhanced health security

South African Minister of Health, Dr Aaron Motsoaledi, described the trial as “a historic milestone, not only for Biovac and our nation, but for the entire continent”. 

“Building local vaccine manufacturing capability is not a luxury; it is a national necessity. It strengthens our sovereignty, enhances our health security, and ensures that our people are not left behind when the next global health crisis strikes,” said Motsoaledi. 

“When we can research, develop, and manufacture vaccines locally, we reduce our vulnerability to supply chain disruptions, geopolitical pressures, international market competition and vaccine hoarding or vaccine nationalism, which was apparent during the height of COVID-19 pandemic.”

The African Union has set a target for 60% of all routine vaccines used in Africa to be manufactured on the continent by 2030, a major advancement from today’s level of less than 1%.

Gavi, the Vaccine Alliance, has put incentives in place for African-made vaccines, putting Biovac in a strong position to secure market share and making it a frontrunner in the bid to sell the vaccine to African countries and those who need it.

Gavi’s African Vaccine Manufacturing Accelerator (AVMA) will make up to $1 billion available over the next 10 years to support the growth of Africa’s medicines and vaccines manufacturing base.

The Biovac vaccine development project is supported by the Gates Foundation, Open Philanthropy, Wellcome, and the ELMA Vaccines & Immunization Foundation, among others.

Florian von Groote, Wellcome’s head of clinical research (infectious disease), said that the trial “could be a major step in strengthening the African vaccine manufacturing landscape, showing that local manufacturers can make vaccines that meet the needs of communities on the continent.

“Through long-term support and investment, local manufacturing can deliver accessible and affordable vaccines made by Africa, for Africa.” 

Image Credits: WHO.

London heat wave in June 2024; climate change has triggered more extreme heat events, and related mortality, in rich and poor countries alike.

A $300 million investment in projects integrating health into climate action has been announced at the UN Climate Conference in Bélem, Brazil by a coalition of “Climate and Health Funders Coalition” which includes over 35 of the world’s leading philanthropies and foundations, including Rockefeller, Gates and Wellcome. 

This announcement was made at the high-level opening of the COP30 Health Day – where a new Bélem Health Action Plan was launched. The Action Plan aims to thrust climate adaptation for the health sector more squarely into the centre of climate actions and tracking, making it part of the global stocktaking exercise. 

“Adaptation is a question of survival in the short run,” declared Brazil’s Minister of Health,  Alexandre Padilha, while launching the Action Plan. “The most recent Lancet Countdown Report on Climate and Health is clear – 3.3 to 3.6 billion people live in highly vulnerable climate areas – and hospitals [in those areas] face a 41% risk of suffering from extreme weather events.

Alexandre Padilha, Brazilian Minister of Health, at COP30 Health Day

“If you don’t adapt, it threatens the coverage of health services of patients and professionals who are already facing adverse conditions. If we don’t adapt, we are going to increase inequality. In short, if you don’t adapt, we will kill people,” he added.

The funding coalition aims to “accelerate solutions, innovations, policies and research on extreme heat, air pollution and climate-sensitive infectious diseases,” the partners said in a press release Thursday. 

While the $300 million commitment may be a drop in the bucket of needs, the aim is to expand the fund, coalition members told Health Policy Watch:

“It is just initial funding and we intend to bring in more philanthropies in the year ahead as well as work with other sectors to significantly increase funding for climate and health solutions,” said Garth Davies, a spokesperson for Wellcome.

See related story: Brazil Wins Limited Backing for COP30 Climate-Health Plan, But Nations Commit No Finance

COP30 is currently underway in Brazil’s Amazon region city of Belém.


“The warnings from scientists on climate change have become reality. And, it is clear that not all people are affected equally”, said John-Arne Røttingen, Wellcome CEO. “The impacts of rising temperatures hit the most vulnerable people hardest – children, pregnant people, older people, outdoor workers and those communities with the least resources to respond. Every country in the world is now affected by climate change, and we need to develop and implement solutions fast to save lives and livelihoods.” 

“Every person should have the opportunity to live a healthy, productive life, no matter where they were born,” said Steve Davis, Senior Advisor for Philanthropic Partnerships at the Gates Foundation. 

“But a hotter world with less predictable and more extreme weather is threatening that vision for the future, particularly for people in low- and middle-income countries. Philanthropy has a unique role to play in contributing flexible funding to accelerate innovative solutions that protect health and help communities build resilience to climate shocks,” he said. 

Other big names in the development sector that have signed onto the coalition plan include: Bloomberg Philanthropies, Children’s Investment Fund Foundation, IKEA Foundation, Quadrature Climate Foundation, and Philanthropy Asia Alliance.

Climate data and heat adaptation 

Women in Bangladesh queue for drinking water in the southwestern coastal region, facing increased saltwater intrusion linked to storm surges and sea level rise that climate change has worsened.

The Coalition’s funds are aimed to “support” the Bélem Health Action Plan through funding of projects on the ground, Davies said, citing projects on: adaptation to extreme heat in India, collecting climate and weather data in Africa, and combating air pollution, whose emissions also contribute to climate change: 

“In extreme heat, one example organization the Coalition is supporting is the Indian nonprofit Self-Employed Women’s Association (SEWA). SEWA is the largest movement of informal workers in India – and one of the largest in the world – with over 3.2 million members. SEWA works to address the threats that extreme heat poses to health and livelihoods.”

Another project receiving support is The African Centre of Meteorological Application for Development (ACMAD). It is the primary pan-African centre working to collect, analyze, and disseminate weather and climate data across the continent, supporting national meteorological agencies and governments in all 53 African countries.

“By coming together to align our priorities and combine our resources, this coalition can accelerate solutions faster, reach more communities, and achieve greater impact. This is the power of collaboration: recognizing the urgency of the challenge and working as one to protect lives, strengthen health systems, and build resilience for communities around the world,” said Naveen Rao, Senior Vice President of Health at The Rockefeller Foundation, in the press release.

Making the Bélem COP, a health COP

Through the Belém Health Action Plan, officials want to make this COP, a “health COP.”

Brazilian authorities have long said that they hope to make this COP a “health COP” – after it played a largely backstage role at COP29 in Azerbaijan. COP28 featured the first Health Day at a UN Climate Conference, with high-powered speakers like Bill Gates and then-US Climate Envoy John Kerry on the podium.  

While the health impacts of climate change have been intensifying, health has, however, remained on the fringes of mainstream COP debates and decisions. 

It remains to be see if the Belém Health Action Plan can win widespread political buy-in and finance to empower countries to make health a more central element in their climate action agendas in the health sector.  

Along with “adaptation”, however, the massive health benefits of mitigating climate change in other sectors from transport to energy production and housing, have yet to be formally recognized by climate negotiators – benefits that could save tens of millions of lives across the coming decade, through reduced heat exposures, less air pollution, and more physical activity as well as healthier diets and food security.  

“The health consequences of climate change are mounting, and they fall hardest on communities least equipped to respond. By supporting the Climate and Health Funders Coalition, we’re working to build health systems that are resilient, equitable, and prepared for the challenges ahead,” said Jess Ayers, CEO of the Quadrature Climate Foundation.

Image Credits: Abir Abdullah / Climate Visuals, Alastair Johnstone / Climate Visuals, X/@Cop30noBrasil, X/@Cop30noBrasil.